Scientific services company aims to expand its testing, analysis and characterisation capabilities
EAG Inc, a global provider of scientific services to a number of industries, including life sciences, has combined its 11 brands under a singular entity called EAG Laboratories.
San Diego, CA, US-based EAG has made multiple acquisitions in recent years and says the move will bring together the firm's broad capabilities in the materials, engineering and life sciences sectors.
'Over the last decade, EAG has quietly added capabilities through complementary acquisitions and service line expansions in the high-growth contract research and testing space,' said Siddhartha Kadia, President and CEO, EAG Laboratories. 'We’ve built a problem-solving culture in which our scientists and engineers go beyond simply delivering data; they interpret results and find answers that support our clients’ commercial success. By unifying multidisciplinary expertise under one brand, we simplify delivery of our services to enhance our customer relationships.'
The following brands will now be known as EAG Laboratories: Evans Analytical Group, ABC Laboratories, Chemir Analytical Services, SEAL Laboratories, PTRL West, PTRL Europe, Wildlife International, Shiva Technologies, NanoScience, Accurel and MEFAS.
EAG Laboratories offers an extensive range of testing, analytical and characterisation services (including environmental testing, custom synthesis and radio-labelling, drug development, materials testing, contaminant identification, failure analysis, engineering services, consulting and expert testimony to companies in the pharmaceutical, biopharmaceutical, medical devices, aerospace, defence and semiconductor industries, among others.
EAG Laboratories’ most recent acquisition was in July 2015, when it added ABC Laboratories to its portfolio. Offering development of cGMP and GLP-compliant testing capabilities for small- and large-molecule therapies and medical devices, ABC Laboratories strengthened EAG’s US and European testing, analysis and characterisation service offerings for the pharmaceutical and other markets.